Important: This information is for educational purposes only. Always consult with qualified healthcare professionals for medical advice, diagnosis, or treatment of hantavirus infection.
Overview
Hantavirus pulmonary syndrome (HPS) is a serious illness with a fatality rate of approximately 38% in confirmed cases. Early recognition, aggressive supportive care, and specialized treatment are critical for survival. Currently, there is no cure, but early treatment can significantly improve outcomes.
Treatment Approaches
Intravenous Immunoglobulin (IVIG)
Case studies
Effectiveness:
Limited data; theoretical benefit in early infection
Polyclonal immunoglobulin containing antibodies that may neutralize hantavirus. Still investigational but showing potential.
Possible Side Effects:
Allergic reactions, thrombosis, headache, fever. Requires careful infusion rate control.
Availability:
Ribavirin (Virazole)
Clinical trial
Effectiveness:
Approximately 30-40% reduction in mortality when given within first 7 days of symptom onset
Nucleoside analog with broad-spectrum antiviral activity. Shows promise in reducing mortality when administered early in HPS infection. IV formulation most effective.
Possible Side Effects:
Teratogenic (causes birth defects), hemolytic anemia, cough, dizziness. Requires careful monitoring of renal function.
Availability:
Careful Electrolyte Management
Case studies
Monitor and replace potassium, sodium, magnesium during recovery phase
Important Notes:
Hyperkalemia or hypokalemia if over-corrected
Fluid Management
Clinical trial
Careful IV fluid replacement while avoiding pulmonary edema. Critical balance required.
Important Notes:
Pulmonary edema if fluids excessive; electrolyte imbalances if inadequate
Platelet Transfusions
Clinical trial
Maintain platelets >10,000-20,000 given hemorrhagic tendency in HPS
Important Notes:
Transfusion reactions, fluid overload
Vasopressor Support
Clinical trial
Norepinephrine and other vasopressors for hypotension management in cardiopulmonary phase
Important Notes:
Tachycardia, arrhythmias, tissue ischemia if over-utilized
Mechanical Ventilation
Essential supportive care for patients with respiratory failure. ECMO (extracorporeal membrane oxygenation) recommended for severe cases.
No prevention measures listed.
When to Seek Emergency Care
Seek immediate medical attention if you experience:
Fever and severe muscle aches (often in back, hips, and legs)
Headache, dizziness, chills
Nausea, vomiting, or abdominal pain
Cough or difficulty breathing
Shortness of breath, especially within 1-2 weeks of symptom onset